Treat high blood pressure sooner: Tougher, simpler JNC 7 guidelines

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 8, 2003, Pages 721-728

  Vidt, Donald G ^a   Borazanian, Raymond A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ALGORITHM; CARDIOVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DRUG INDICATION; HEALTH PROMOTION; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE; MOTIVATION; PATIENT ATTITUDE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0042976559     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.8.721     Document Type: Review

References (23)

1. Chobanian AV, Bakris GL, Black HR, et al and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289:2560-2572.
2. Sheps SG, Black HR, Cohen JD, et al. The sixth report of the Joint national Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
3. Izzo JL Jr, Levy D, Black HR. Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension 2000; 35:1021-1024.
4. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease, overall findings and differences by age for 316,099 white men. Arch Intern Med 1992; 152:56-64.
5. Hyman DJ, Pavlik VN. Poor hypertension control: let's stop blaming the patients. Cleve Clin J Med 2002; 69:793-799.
6. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA 1977; 237:255-261.
7. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
8. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
9. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-1010.
10. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in nonhypertensive populations in The Framingham Heart Study. Lancet 2001; 358:1682-1686.
11. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002; 360:1903-1913.
12. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. Arch Intern Med 1997; 157:657-667.
13. He J, Whelton PK, Appel LI, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35:549-554.
14. Sacks FM, Svetkey LP, Vollmer WM, et al, for the DASH-sodium collaborative research group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344:3-10.
15. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure. Ann Intern Med 2001; 135:1019-1028.
16. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension 2000; 35:858-863.
17. Kelly GA, Kelley KS. Progressive resistance exercise and resting blood pressure. Hypertension 2000; 35:838-843.
18. Whelton SP, Chin A, Zin X, He J. Effect of aerobic exercise on blood pressure. Ann Intern Med 2002; 136:493-503.
19. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure. Hypertension 2001; 38:1112-1117.
20. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA 1997; 277:739-745.
21. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288:2981-2997.
22. Wing LMH, Reid CM, Ryan P, et al for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348:583-592.
23. Hansson L, Zanchetti A, Carruthers SG, et al for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.